Mode of Death in Octogenarians Treated With Cardiac Resynchronization Therapy

Pieter Martens1, Frederik H Verbrugge2, Petra Nijst1

  • 1Department of Cardiology, Ziekenhuis Oost-Limburg, Genk, Belgium; Doctoral School for Medicine and Life Sciences, Hasselt University, Diepenbeek, Belgium.

Insights

Older adults (octogenarians) receiving cardiac resynchronization therapy (CRT) experience significant symptomatic and remodeling benefits, with survival rates comparable to the general age-matched population.

Area of Science:

  • Cardiology
  • Geriatric Medicine
  • Heart Failure Management

Background:

  • Cardiac resynchronization therapy (CRT) is established for heart failure with reduced ejection fraction (HFrEF) and electrical dyssynchrony.
  • Clinical CRT populations are typically older than those in clinical trials.

Purpose of the Study:

  • To evaluate clinical response, reverse remodeling, outcomes, and causes of death in octogenarians undergoing CRT.
  • Compare octogenarians with younger patients receiving CRT.

Main Methods:

  • Retrospective analysis of 686 CRT patients, including 178 octogenarians.
  • Assessed changes in NYHA class, ejection fraction, and ventricular dimensions.
  • Compared heart failure readmissions, all-cause mortality, and mode of death.
  • Compared octogenarian CRT mortality with age-matched general population data.

Main Results:

  • Octogenarians showed similar improvements in NYHA class, ejection fraction, and ventricular size compared to younger patients.
  • Octogenarians had higher all-cause mortality but similar heart failure readmission rates.
  • Non-cardiac deaths were more prevalent in octogenarians; worsening heart failure was the primary cardiac cause of death.
  • Octogenarians receiving CRT had an annual mortality rate equivalent to the age-matched general population.

Conclusions:

  • Octogenarians benefit significantly from CRT, showing comparable symptomatic and remodeling responses to younger patients.
  • Survival in octogenarians receiving CRT is similar to the general age-matched population.
  • CRT is a viable treatment option for selected octogenarians with HFrEF and dyssynchrony.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
702
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
497
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
611
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
775
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
574
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.2K